Details of the Drug

General Information of Drug (ID: DMU9SL8)

Drug Name
BIIB063
Indication
Disease Entry ICD 11 Status REF
Sjogren syndrome 4A43.20 Phase 1 [1]
Cross-matching ID
TTD ID
D0XE2O

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)